The Agony of Hives: What To Do When Welts and Swelling Do Not Go Away
This webinar is a recording of a live event held on 4 April 2017 for World Allergy Week.
Access the webinar. (Note: Login required.)
Paul Greenberger, MD
Feinberg School of Medicine Northwestern University
The impact and agony of chronic hives
Global prevalence – what has been reported
Marcus Maurer, MD
Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité – Universitätsmedizin
Current approaches to treatment
Mario Sánchez Borges, MD
Centro Médico Docente – La Trinidad; Clínica El Avila
Diagnosing and managing patients with aspirin or NSAID-induced urticaria
Elham Hossny, MD, PhD
Children’s Hospital of Ain Shams University
Chronic urticaria and the pediatric patient
For distribution support through an unrestricted education grant WAO thanks Novartis.
Join Us for the Upcoming
World Allergy Forum!
Mechanisms and Complications of Severe Asthma
Monday, 19 June 2017 from 10:45 AM to 12:15 PM
Messukeskus Congress Center, Helsinki Finland
Mario Sánchez Borges, MD, Centro Médico Docente – La Trinidad; Clínica El Avila, Venezuela
Peter W. Hellings, MD, PhD, KU Leuven and University of Amsterdam, The Netherlands
PROGRAM AND FACULTY
Fungal Interference in Severe Asthma
David B. Corry, MD
Baylor College of Medicine, United States
TSLP and IL-33 Basic Immunology/Biology in Severe Asthma
Steven F. Ziegler, PhD
Benaroya Research Institute at Virginia Mason, United States
Steroids and Vitamin D in Severe Asthma
Catherine M. Hawrylowicz, PhD
Guy's Hospital, King's College, United Kingdom
This World Allergy Forum symposium is an initiative of the WAO Collaboration on Severe Asthma (COSA). Learn more about COSA publications and education activities at: www.worldallergy.org/severe-asthma.
For support through independent education grants, WAO thanks Teva Pharmaceuticals, founding supporter, and Sanofi Genzyme and Regeneron Pharmaceuticals.
WAO is now accepting applications to be recognized as a WAO Center of Excellence. Please visit the WAO Centers of Excellence website to learn more about WAO Centers of Excellence, or to find a center near you.
For additional details on how to become a WAO Center of Excellence and to apply, please visit the Application Page. The deadline to apply is 30 September 2017.
Which patients might respond to bronchial thermoplasty as an option for difficult-to-treat severe asthma? What is the long-term outlook? What are the complications?
Learn more in this new cased-based learning module from Dr. Reynold A. Panettieri, Jr., Vice Chancellor for Translational Medicine and Science, Rutgers Institute for Translational Medicine & Science, Rutgers University.
Learning Objectives: Understand the clinical complexities of severe asthma, the treatment paradigms for severe asthma, and the role of bronchial therapy in the management of severe asthma.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the World Allergy Organization. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this internet enduring material for a maximum number of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement: WAO thanks Boston Scientific for support through an independent education grant.
Access the module
Login required; access is free